Clinical Trials Browser

Phase NA × Osteosarcoma × apatinib × Clear all

NCT04690231 2022-03-15

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Phase NA Completed

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions